Showing results (61-70 of 257) with videos related to
Sort By:
Pageof 26
BMC Gastroenterology|February 19, 2014
Management of the HBV reactivation in isolated HBcAb positive patients affected with Non Hodgkin LymphomaMario Masarone, Amalia De Renzo, Vincenzo La Mura, et al.Blood Reviews|April 12, 2025
Navigating acute myeloid leukemia towards better outcomes: Treatment pathways and challenges for patients ineligible for intensive chemotherapyRaffaele Palmieri, Anna Candoni, Francesco Di Raimondo, et al.Hematological Oncology|October 13, 2006
Myeloablative chemotherapy followed by autologous stem cell infusion may overcome the adverse prognostic impact of FLT3 (foetal liver tyrosine kinase 3) mutations in patients with acute myeloid leukaemia and normal karyotypeSalvatore Palmieri, Felicetto Ferrara, Franco Leoni, et al.Haematologica|November 11, 2003
Hepatitis B virus reactivation after fludarabine-based regimens for indolent non-Hodgkin's lymphomas: high prevalence of acquired viral genomic mutationsMarco Picardi, Fabrizio Pane, Concetta Quintarelli, et al.Acta Cytologica|March 2, 2012
Fine-needle cytology and flow cytometry assessment of reactive and lymphoproliferative processes of the breastElena Vigliar, Immacolata Cozzolino, Laura Virginia Sosa Fernandez, et al.BMC Cancer|January 8, 2014
Lymph node fine needle cytology in the staging and follow-up of cutaneous lymphomasElena Vigliar, Immacolata Cozzolino, Marco Picardi, et al.Bone Marrow Transplantation|January 26, 2019
Eltrombopag for post-transplant cytopenias due to poor graft functionSerena Marotta, Luana Marano, Patrizia Ricci, et al.European Journal of Haematology|March 8, 2020
The multi-tyrosine kinase inhibitor ponatinib for chronic myeloid leukemia: Real-world dataLuigia Luciano, Mario Annunziata, Immacolata Attolico, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|May 1, 2017
Secondary syphilis mimicking malignancy: A case report and review of literatureClaudio Cerchione, Alberto Enrico Maraolo, Luana Marano, et al.Blood|July 2, 2008
Cytotoxic T lymphocytes directed to the preferentially expressed antigen of melanoma (PRAME) target chronic myeloid leukemiaConcetta Quintarelli, Gianpietro Dotti, Biagio De Angelis, et al.Pageof 26